Eric Gorman has extensive experience in pharmaceutical research and development, currently serving as Director at Gilead Sciences since April 2011 and progressing through several research scientist positions. Prior roles include a Graduate Research Assistant at The University of Kansas from June 2004 to March 2011, and internships at Pfizer, Schering Plough, and Bristol-Myers Squibb. Eric Gorman holds a PhD and MS in Pharmaceutical Chemistry from The University of Kansas and a BS in Pharmaceutical Sciences from Drake University. Key contributions include the development of real-time reaction monitoring technology and solid-state NMR spectroscopy characterization for formulation development.
This person is not in any teams
This person is not in any offices